引用本文:黄恒海,薛元领,黄志红,郑赓唐.髂内动脉-前列腺动脉化疗栓塞治疗晚期前列腺癌[J].中国临床新医学,2009,2(12):1257-1259.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1396次   下载 900 本文二维码信息
码上扫一扫!
分享到: 微信 更多
髂内动脉-前列腺动脉化疗栓塞治疗晚期前列腺癌
黄恒海,薛元领,黄志红,郑赓唐
543001 广西,梧州市工人医院泌尿外科
摘要:
[摘要] 目的 探讨经髂内动脉-前列腺动脉化疗栓塞晚期前列腺癌的疗效。方法 对22例晚期前列腺癌患者其中C1期5例,C2期7例,D1期8例,D2期2例,共行25次介入治疗。所用药物剂量分别是:卡铂400 mg,丝裂霉素20 mg,表阿霉素50 mg,长春新碱1 mg;栓塞剂选用明胶海绵和碘甘油。结果 22例患者自治疗后第1周,病人均出现前列腺质地变软和体积缩小;第2~3周后体积缩小20%~40%;3例术后有神经合并症;1例臀部皮肤组织缺血坏死;8例于化疗栓塞2~3周后行经尿道前列腺汽化电切术。随访5~36个月,尿流率明显改善,残尿量减少或消失。结论 经导管双侧髂内动脉超选择(前列腺动脉)化疗栓塞治疗晚期前列腺癌疗效肯定,为综合治疗晚期前列腺癌增加了新的治疗手段,尤其是对非雄性激素依赖性前列腺癌或内分泌治疗无效者更有意义。
关键词:  前列腺癌  介入性化疗  栓塞  髂内动脉-前列腺动脉
DOI:10.3969/j.issn.1674-3806.2009.12.11
分类号:R 737.25
基金项目:广西壮族自治区梧州市基金项目(合同编号:200501044)
Intra-iliac arterial prostatic arterial chemo-embolization in the treatment of advanced prostate cancer
HUANG Heng-hai, XUE Yuan-ling, HUANG Zhi-hong, et al.
Department of Urology, Wuzhou Workers Hospital, Guangxi 543001, China
Abstract:
[Abstract] Objective To study the effect of trans-intra-iliac arterial prostatic arterial chemo- embolization in the treatment of advanced prostate cancer. Methods The therapy was performed in 22 patients with advanced prostate cancer for 25 times. Five cases were in stage C1; 7 in stage C2; 8 in stage D1; 2 in stage D2. The drug dose was CBP 400 mg, MMC 20 mg, epirubicin 50 mg, VCR 1.0 mg and the embolic agent was gelfoam. Results After one week of the therapy, the symptoms of all the patients were relieved and their prostates got softened and regressed. After 2~3weeks of the therapy, the regression rate was 20%~40%. The neuro-complications occurred in 3 cases. And 8 cases were treated with urethroelectrotomy after embolization. The follow up time was 5~36 months. Results showed their urinary fllow rate was improved and residual urine volume diminished or eliminated. Conclusion Transcathter bilateral intra-iliac superselective chemo-embolization has a positive effect on advanced prostate cancer. It has provided a new method for the comprehensive treatment of advanced prostate cancer, especially for those which belong to androgenic-hormone dependent type, or those which are non-sensetive to the endocrine treatment.
Key words:  Prostate cancer  Interventional chemotherapy  Embolization  Intra-iliac arterial-prostatic artery